CA

Michel Trudel


Average Co-Inventor Count = 4.0

ph-index = 3

Forward Citations = 36(Granted Patents)


Location History:

  • Quebec, CA (2000 - 2003)
  • Lorraine, CA (2007)

Company Filing History:


Years Active: 2000-2007

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Michel Trudel: Innovator in Immunogenic Research

Introduction

Michel Trudel is a prominent inventor based in Canada, known for his significant contributions to the field of immunogenic research. With a total of 5 patents to his name, he has made strides in developing innovative solutions for respiratory syncytial virus (RSV) treatment.

Latest Patents

Among his latest patents is a groundbreaking polypeptide that serves as an immunogen element. This polypeptide is characterized by its peptide sequence between amino acid residues 130–230 of the G protein sequence of the human respiratory syncytial virus of sub-groups A and B, or the bovine respiratory syncytial virus. The patent also includes an immunogenic agent or pharmaceutical composition containing this polypeptide, along with methods for preparing and utilizing the same.

Career Highlights

Michel Trudel has established a successful career at Pierre Fabre Medicament, where he has focused on advancing pharmaceutical compositions and immunogenic agents. His work has been pivotal in addressing viral infections and enhancing therapeutic options.

Collaborations

Throughout his career, Michel has collaborated with notable professionals in the field, including Hans Binz and Thierry Baussant. These collaborations have further enriched his research and development efforts.

Conclusion

Michel Trudel's innovative work in immunogenic research and his contributions to the field of virology underscore his importance as an inventor. His patents reflect a commitment to advancing medical science and improving health outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…